This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Masimo and Philips renewed a multi-year strategic ...

Under new April 2020 FDA guidance [1], the Avalon CL Fetal and Maternal Pod and Patch are now available in the U.S., in addition to existing countries in Europe, Australia, New Zealand and Singapore, ...

AMSTERDAM & DALLAS--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) and Children’s Health SM today announced an up to 15-year, long-term, strategic agreement worth up to USD $75 million to ...

By bringing together Philips’ deep expertise in patient monitoring and Masimo’s advanced noninvasive technologies, the collaboration is focused on delivering integrated, clinically validated solutions ...

Royal Philips is adding another remote-monitoring platform to its portfolio with its planned acquisition of Cardiologs. The Paris-based company uses ECG data to detect potential cardiac arrhythmias.

Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable. The collaboration allows vital sign data from the W1 watch to be sent ...

Royal Philips joins the list of companies taking advantage of the relaxed FDA guidelines with its plans to launch its prenatal monitoring platforms in the U.S. The Fetal and Maternal Pod and Patch ...

Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Telemetry overuse can burden frontline teams ...

Philips Healthcare's e-Alert magnetic resonance imaging monitoring software has a security vulnerability that could potentially allow an unauthorized user to remotely shut down the system, according ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.